Controllable release is particularly important for the delivery of small interfering RNA (siRNA), as siRNAs have a high susceptibility to enzymatic degradation if release is premature, yet lack silencing activity if they remain inaccessible within the cytoplasm. To overcome these hurdles, novel and tailorable mPEG-b -poly(5-(3-(amino)propoxy)-2-nitrobenzyl methacrylate) (mPEG-b -P(APNBMA)) diblock copolymers containing light-sensitive onitrobenzyl moieties and pendant amines are employed to provide both effi cient siRNA binding, via electrostatic and hydrophobic interactions, as well as triggered charge reversal and nucleic acid release. In particular, siRNA/ mPEG-b -P(APNBMA) 23.6 polyplexes show minimal aggregation in physiological salt and serum, and enhanced resistance to polyanion-induced unpackaging compared to polyethylenimine preparations. Cellular delivery of siRNA/ mPEG-b -P(APNBMA) 23.6 polyplexes reveals greater than 80% cellular transfection, as well as rapid and widespread cytoplasmic distribution. Additionally, UV irradiation indicates ≈70% reduction in targeted gene expression following siRNA/mPEG-b -P(APNBMA) 23.6 polyplex treatment, as compared to 0% reduction in polyplex-treated cells without UV irradiation, and only ≈30% reduction for Lipofectamine-treated cells. The results here highlight the potential of these light-sensitive copolymers with a well-defi ned on/off switch for applications including cellular patterning for guided cell growth and extension, and cellular microarrays for exploring protein and drug interactions that require enhanced spatiotemporal control of gene activation.
Introduction
Small interfering RNA (siRNA) has emerged as a promising tool for modulating gene expression and offers signifi cant opportunities for the treatment of a range of acquired and hereditary diseases. [ 1 ] However, the clinical application of siRNAs has been limited by their high susceptibility to enzymatic hydrolysis, rapid clearance from systemic circulation, limited cellular uptake, and inability to effi ciently traffi c to the cytoplasm of cells. [ 2 ] In particular, the diffi culty in controlling binding versus release of siRNAs is a key factor limiting translation of siRNA degrees of deacetylation when using chitosan molecules with molecular weights greater than ≈65 kDa, and identifi ed aggregates greater than 500 nm for lower-molecular-weight preparations. Hydrophobic modifi cation of polycations also has been explored to improve the binding affi nity in gene delivery carriers by providing co-operative binding interactions, [ 9a , 11 ] and hydrophobic modifi cation also enhances serum stability [ 12 ] and increases adsorption to the cell membrane. [ 13 ] However, with all such approaches, the ability to suffi ciently enhance siRNAbinding affi nity for extracellular stabilization has been hindered by the need for siRNA liberation prior to assembly of the RNAinduced silencing complex in the cytoplasm. [ 6a,b ] For example, in the use of linear polyethylenimine (PEI) for siRNA delivery, Shim et al. [ 6b ] reported limited siRNA unpackaging and lowgene-silencing effi ciency despite effi cient cellular uptake and cytoplasmic localization of these structures, and other studies have reported similar effects. [ 5a , 14 ] As such, a delivery strategy that balances the requirements of strong binding stability during circulation and reduced binding stability in the cytosol is particularly attractive.
The need to control siRNA binding versus release has motivated the development of stimuli-responsive carriers whose interactions with siRNA depend upon intracellular or externally applied cues. [ 6c , 15 ] For example, Kwon and co-workers demonstrated effi cient gene silencing using acid-degradable ketalized linear PEI (KL-PEI). [ 6b ] ,c Intravenous injection of PEGylated siRNA/KL-PEI polyplexes targeting green fl uorescent protein (GFP) produced signifi cantly reduced GFP mRNA and protein levels in solid tumors as well as whole blood of mice. Stimuli-responsive carriers with sensitivity to external triggers (e.g., light, magnetic fi elds, or ultrasound) offer increased fl exibility in timing and localization of nucleic acid release, which further motivates their application in gene-transfer systems requiring activation of genes in defi ned cellular subpopulations, including efforts to engineer complex tissue architectures. [ 16 ] Photoresponsive materials are particularly attractive due to the versatility in photoresponsive chemistries and spatial resolution afforded by light. In fact, delivery vehicles containing the o -nitrobenzyl ( o -NB) linker undergo structural changes in response to ultraviolet (UV) and near-infrared (NIR) irradiation and have enabled light-triggered release of siRNA. [ 17 ] For example, Li et al. [ 18 ] recently demonstrated cationic amphiphilic macromolecules with a single photolabile NB linker between a long hydrophobic alkyl tail and a cationic/hydrophilic head for siRNA complexation. These amphiphiles assembled in aqueous solution into micelles and bound siRNA within the cationic corona. While UV cleavage of surface-associated siRNA resulted in reduced luciferase expression following in vitro delivery to MDA-MB-231 (human breast cancer) cells, the amphiphiles did not demonstrate the enhanced binding stability necessary for continued siRNA association in the absence of a light trigger. These studies highlight the tremendous potential of photoresponsive carriers for controlling gene expression, and motivate their use to directly activate siRNA release for delivery. However, further enhancements are needed to incorporate strong binding affi nity in concert with activated siRNA release and subsequent gene knockdown.
We recently demonstrated the design and synthesis of mPEG-b -poly(5- (3-(amino) propoxy)-2-nitrobenzyl methacrylate (mPEG-b -P(APNBMA) n ) copolymers with tunable molecular weight, low dispersity, and o -NB-linked pendant ammonium cations to enable light-triggered polymer cleavage and charge reversal (to carboxylate anions) along the P(APNBMA) n backbone. [ 19 ] In that work, mPEG-b -P(APNBMA) 7.9 facilitated efficient pDNA encapsulation, improved salt stability, and lightmediated pDNA release. Additionally, mPEG-b -P(APNBMA) polyplexes did not compromise the viability of mouse embryonic fi broblast (NIH/3T3) cells, either with or without UV light irradiation.
In the present study, we assessed the feasibility of using mPEG-b -P(APNBMA) copolymers containing hydrophobic and cationic binding units as carriers for siRNA. The inclusion of o -NB groups decoupled the binding versus release of the siRNA payload and introduced the capacity for light-responsive initiation of gene silencing. We identifi ed mPEG-b -P(APNBMA) designs and polyplex assembly conditions to facilitate strong siRNA association and stability of these photocleavable structures. Furthermore, polyplex delivery to NIH/3T3 cells revealed high levels of cellular uptake, rapid and widespread cytoplasmic distribution of delivered siRNA polyplexes, and gene-specifi c and light-mediated siRNA release, and silencing in response to UV irradiation, highlighting a unique approach for spatiotemporal control of gene expression.
Results and Discussion

siRNA-Binding Studies
Effi cient siRNA binding typically requires higher N / P ratios and/or higher-molecular-weight polycations as compared with DNA condensation. [ 3 ] Hence, we sought to test the siRNAbinding capacity of mPEG-b -P(APNBMA) n ( M n = 7900 g mol −1 , n = 7.9 or M n = 13 100 g mol
, n = 23.6; Figure 1 A) block copolymers as a function of P(APNBMA) n block length. mPEGb -P(APNBMA) n was added to siRNA at various charge ratios to form siRNA/mPEG-b -P(APNBMA) n polyplexes (Figure 1 B) , and the resulting solutions were analyzed via gel electrophoresis. Previous studies utilizing mPEG-b -P(APNBMA) 7.9 for pDNA delivery indicated effi cient complexation at N / P ≥ 5; however, in the preparation of siRNA polyplexes, mPEG-b -P(APNBMA) 7.9 was unable to effi ciently complex siRNA (Figure 1 C) based on the minimal changes that were noted in ethidium bromide fl uorescence upon polymer addition, as well as the persistence of a free siRNA band for N / P ratios of 10-80. Specifi cally, while there was an initial reduction in ethidium bromide fl uorescence following mPEG-b -P(APNBMA) 7.9 addition at N / P = 10 and small changes in fl uorescence at N / P = 20 and 40, polymer addition above an N / P ratio of 40 did not induce additional polyplex formation. Several research groups have identifi ed similar reductions in siRNA complexation effi ciency with carriers that exhibited high affi nity for DNA. [ 10c , 20 ] In contrast, mPEG-b -P(APNBMA) 23.6 provided suffi ciently strong interactions to complex siRNA at low N / P ratios (Figure 1 D) . Upon addition of mPEG-b -P(APNBMA) 23.6 at N / P = 0.5, there was an initial ≈83% reduction in ethidium bromide fl uorescence. Further addition of the polymer ( N / P ≥ 1) fully inhibited migration and low levels of fl uorescence became visible in the wells. The fl uorescence in the wells decreased with continued polymer addition, and disappeared completely above an N / P of 4, suggesting that mPEG-b -P(APNBMA) 23.6 effectively complexed siRNA. Several studies have indicated effective condensation of siRNA using PEG-amine methacrylate block copolymers, which display similar architectures to mPEG-b -P(APNBMA). [ 21 ] For example, Duvall and co-workers reported siRNA complexation at N / P ≥ 1 for PEG-b -PDMAEMA (M n = 17 000 g mol −1 ) by using electrophoresis.
[ 9a ] Additionally, Rice and co-workers previously demonstrated that the stability of polyplex association could be enhanced through the incorporation of hydrophobic acridine groups into polycations. [ 11c ] Given the high siRNA-binding affi nity of mPEG-b -P(APNBMA) 23.6 , it is possible that the cationic and hydrophobic components in the APNBMA block may cooperatively condense and stabilize the siRNA/mPEG-b -P(APNBMA) 23.6 structures.
Physical Characterization of Polyplexes
Formed with mPEG-b -P(APNBMA) 23.6 Based on the increased binding effi ciency of the 23.6 repeat unit copolymer, this polymer was used for subsequent investigations. The hydrodynamic diameters ( D H ) of siRNA/ mPEG-b -P(APNBMA) 23 .6 polyplexes were measured using dynamic light scattering (DLS) ( Figure 2 A) to determine whether these structures would be suitable for cellular uptake, as well as to determine whether D H decreased as polymer-binding affi nity (and N / P ratio) increased. Polyplexes were formed at varied charge ratios ranging from N / P = 2 to 8 based on the electrophoretic complexation data. The values of polyplex D H for all polyplex formulations were below 150 nm, signifi cantly lower than the size limit that has been suggested for endocytic uptake (<200 nm). [ 22 ] Furthermore, the sizes of the siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes were relatively constant as a function of N / P . These fi ndings indicated a high binding affi nity between siRNA and the longer polycation, consistent with electrophoresis data. Furthermore, the effi cient siRNA complexation combined with the small D H at N / P ≥ 4 revealed an enhanced siRNA binding capacity compared to other PEG-polycation block copolymers used for siRNA delivery. [ 23 ] Stealth coatings such as PEG are well known to promote colloidal stability and resist non-specifi c protein adsorption and opsonization in a number of gene delivery structures. [ 24 ] Thus, we tested if the incorporation of the PEG block provided nonfouling characteristics in the presence of physiological salt solutions and serum. Polyplexes were incubated in phosphatebuffered saline (PBS, 150 m M NaCl) or Opti-MEM (transfection medium containing protein supplements). Subsequently, the average D H values of the polyplexes were measured by DLS to determine whether the polyplexes exhibited salt-or Figure 1 . A) Chemical structure of mPEG-b -P(APNBMA) n polymers. B) Cartoon schematic of siRNA/mPEG-b -P(APNBMA) n polyplex formation. Representative siRNA mobility assay of C) siRNA/mPEG-b -P(APNBMA) 7.9 and D) siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes in 4 wt% agarose gels stained with ethidium bromide. Lane 1 of both gels is siRNA alone ( N / P = 0), while the remaining lanes show siRNA complexed with polymer at varied N / P ratios. Tabulated values indicate percentages of free siRNA based on ImageJ analysis of the free siRNA band. serum-induced changes in size as compared with polyplexes that were incubated in formulation buffer (20 m M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer, pH 6.0) (Figure 2 B) . The polyplex sizes remained constant at ≈120 nm following 1 and 3 h incubations in Opti-MEM at 23 °C. Incubation in PBS over a 3-h period resulted in a slight increase in polyplex size from ≈130 nm at 1 h to ≈145 nm following a 3 h incubation. In contrast, Zhao et al. [ 25 ] reported siRNA/PEI (25 kDa) polyplexes greater than 1 µm in diameter following a 1 h incubation in physiological saline (150 m M NaCl). In the presented studies, all polyplexes retained small sizes that were below the 200 nm threshold for endocytic uptake. [ 26 ] Based on the relative stability of the polyplex structures and the minimal increase in D H , these studies suggested that the PEG block formed a protective corona following polyplex formation to resist both salt-induced aggregation and protein adsorption.
Polyanionic glycosaminoglycans (GAGs) such as heparin are major components of the extracellular matrix and have been shown to displace nucleic acids from their cationic carriers in numerous studies. [ 5a , 27 ] Thus, to evaluate the stability of mPEGb -P(APNBMA) 23.6 polyplexes against competing polyanions, we tested the susceptibility of these polyplexes to heparin displacement as compared with siRNA/PEI polyplexes. siRNA/ PEI polyplexes were prepared at N / P = 6 to ensure effective binding of siRNA, and the mPEG-b -P(APNBMA) 23.6 and PEI polyplexes were incubated with increasing heparin concentrations. Polyplex dissociation and siRNA release were monitored by electrophoresis ( Figure 3 ). Gel mobility assays indicated greatly enhanced heparin stability for mPEG-b -P(APNBMA) 23.6 structures, which continued to associate with siRNA and exclude ethidium bromide fl uorescence in the wells of the gel for heparin/siRNA (w/w) ratios ≤ 1.5 (Figure 3 A ). An increase in the heparin/siRNA ratio to 2 resulted in polyplex loosening and demonstrated low levels of fl uorescence in the well of the gel. Further increases of the heparin/siRNA ratio to 5 resulted in ≈10% siRNA dissociation from the mPEGb -P(APNBMA) 23 .6 structures (Figure 3 C). In contrast, PEI preparations indicated siRNA displacement for heparin/siRNA (w/w) ratio ≥ 1.5 (Figure 3 B ) and ≈50% siRNA dissociated for heparin/siRNA (w/w) ratio of 5. A number of studies have identifi ed enhanced polyplex stability through the incorporation of hydrophobic groups. [ 28 ] For example, Duvall and co-workers demonstrated increased stability against heparin-mediated disassembly with increased butyl methacrylate (BMA) content in the use of PEG-b -P(DMAEMA-co -BMA) block copolymers for siRNA delivery. [ 9a ] We hypothesize that hydrophobic groups in the cationic block may provide additional binding interactions to stabilize the siRNA polyplexes and provide increased stability against polyanion-mediated dissociation.
The interactions between serum proteins and polyplexes also can lead to polyplex disassembly and subsequent degradation of siRNA by serum nucleases. Hence, electrophoresis and serum/ nuclease stability assays were performed to assess the structure of the serum-exposed mPEG-b -P(APNBMA) 23.6 polyplexes ( Figure 4 A). Gel mobility shift assays on free siRNA treated with whole mouse serum produced a modest broadening of the siRNA band due to degradation (Figure 4 A, Lane 2) compared to untreated siRNA (Lane 1). In contrast, no free siRNA band was visible for all serum-treated polyplex samples (Lanes 3-7). The increased background fl uorescence in serum-treated samples was attributed to interactions between ethidium bromide and serum components, as similar fl uorescence occurred in the serum control (Lane 8). These data indicated that the siRNA was not displaced from the polyplex following incubation in serum.
siRNA/mPEG-b -P(APNBMA) 23 .6 polyplexes were exposed to RNase A to investigate the susceptibility of encapsulated siRNA to nuclease-mediated degradation (Figure 4 B) . The treatment of free siRNA with RNase A resulted in increased electrophoretic mobility of the siRNA, broadening of the siRNA band, and ≈65% reduction in ethidium bromide fl uorescence intensity (Lane 2). In contrast, siRNA released from RNase A-treated mPEG-b -P(APNBMA) 23 23.6 polyplexes ( N / P = 4), and B) siRNA/PEI polyplexes ( N / P = 6) incubated in the presence of increasing amounts of heparin. C) Quantifi cation of free siRNA in siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes (black) and siRNA/PEI polyplexes (white) based on gel image analysis using ImageJ. Gel mobility shift and nuclease stability analyses of siRNA polyplexes. A) Stability of free siRNA and siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes against serum-mediated disassembly. Free siRNA and siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes prepared at N / P = 2, 4, 6, and 8 were analyzed in the presence (+) or absence (−) of serum. B) Stability of free siRNA and siRNA polyplexes ( N / P = 4) against RNase A-mediated degradation. Free siRNA and siRNA/ mPEG-b -P(APNBMA) 23.6 polyplexes were treated with RNase A (+) or RNase A-free (−) buffers, the nuclease reactions were terminated, and the polyplexes were either disassembled via SDS incubation (+) or left intact (−).
bromide fl uorescence intensity compared to siRNA released from polyplexes without nuclease treatment (Lane 4). These combined serum and nuclease stability results indicated that the binding affi nity of the mPEG-b -P(APNBMA) 23.6 for siRNA was suffi ciently strong to prevent serum-mediated polyplex disassembly and provide enhanced resistance to nuclease degradation.
UV-Induced Unpackaging of siRNA/mPEG-b -P(APNBMA)23.6 Polyplexes
Given the effi cient packaging and enhanced salt and serum stability of siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes, UV irradiation studies were performed to assess the effi cacy of light-triggered siRNA release. Free mPEG-b -P(APNBMA) 23.6 block copolymer as well as siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes were irradiated with 365 nm light, and UV/Vis spectroscopy was used to monitor changes in the characteristic absorbance of the o -NB ester at 316 nm to determine the extent of photocleavage ( Figure 5 ). [ 19 ] The free polymer absorbance spectra displayed dramatic decreases in absorbance at 316 nm for UV exposure times up to 10 min, and smaller changes at longer UV-exposure times (Figure 5 A) . Irradiation of siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes yielded similar results under the same conditions, with a large decrease in absorbance after 10 min of irradiation (Figure 5 B) . This behavior was consistent with the typical cleavage behavior of o -NB-containing polymers, which disassemble in response to irradiation with UV light to form a carboxylic acid and nitrosobenzaldehyde. [ 29 ] The spectral shifts also were similar to those previously noted for mPEGb -P(APNBMA) n in pDNA polyplexes, [ 19 ] and the decrease in absorbance as a function of irradiation time followed an exponential decay for both the polymer and siRNA polyplex preparations. In particular, both the free polymer and polyplex spectra suggested complete cleavage of the o -NB group, based on the change in absorbance at 316 nm.
The irradiated polyplexes were collected and analyzed via electrophoresis to determine the extent of light-induced siRNA release ( Figure 6 A) . When the polyplexes were irradiated for short periods of time (≤10 min irradiation), siRNA migration was limited, but 23.6 and D) siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes as a function of UV irradiation time. The log of the normalized intensity, for which the red dashed line indicates an exponential decay fi t to the normalized intensity. Error bars represent the standard deviation determined from the mean of three independent absorbance measurements. after ≥20 min of exposure, signifi cant amounts of free siRNA migrated down the gel. After 60 min of irradiation, additional siRNA migrated on the gel, yet release remained incomplete. Specifi cally, quantifi cation of the free siRNA band intensities by ImageJ analysis revealed that ≈15% of the siRNA was released after a 20-min irradiation, and the levels of released siRNA increased up to ≈24% as irradiation times increased (Figure 6 B) .
These studies highlight a novel release property that has not been previously demonstrated in other light-sensitive nucleic acid binding polymers. [ 30 ] Specifi cally, this system provides robust polyplex stability against polyanion-or serum-mediated disassembly, along with light-mediated release of a significant fraction of siRNA following light exposure. Light-induced structural changes remove the hydrophobic and cationic moieties responsible for siRNA binding and elicit a charge reversal along the mPEG-b -P(APNBMA) 23.6 polymer backbone, which may account for the enhanced dissociation of the siRNA structures in this work as compared with other approaches. Meanwhile, it is possible that the apparent lack of complete release following irradiation was an artifact in quantifi cation caused by the continued association of cleaved polymer fragments with the siRNA. The continued association of these fragments could reduce ethidium bromide binding, especially given that these fragments contained phenyl rings that might prohibit the intercalation of the ethidium bromide molecules. In previous work, we noted that irradiation of pDNA/mPEG-b -P(APNBMA) 7.9 polyplexes also produced incomplete release of pDNA, although in that case, the released pDNA exhibited reduced mobility. [ 19 ] These distinct behaviors may be caused by differences in siRNA versus pDNA association with polycations, as siRNA/ polycation interactions are weaker; [ 3 ] hence, it is reasonable that the siRNA would exhibit enhanced dissociation from both the polymer backbone and polymer fragments in comparison to pDNA-based polyplexes.
Cellular Uptake of siRNA/mPEG-b -P(APNBMA) 23.6 Polyplexes
Given that mPEG-b -P(APNBMA) 23.6 formed compact, saltand serum-stable polyplexes that released siRNA upon light exposure, the polymer's ability to mediate cellular uptake in NIH/3T3 cells was tested. Polyplexes were formulated with siRNA that was labeled with YOYO-1 iodide, visualized using fl uorescence microscopy, and quantifi ed via fl ow cytometry. Fluorescence microscopy showed rapid uptake of the labeled polyplexes, as indicated by the appearance of large quantities of intracellular YOYO-1-labeled structures after 1 h ( Figure 7 A) . The punctate appearance in many of these structures suggested that the polyplexes were entrapped within endomembrane vesicular compartments within the cells, consistent with previous studies investigating the traffi cking of siRNA polyplexes [ 6b ] and other nanostructures. Notably, at slightly longer periods of polyplex exposure, a diffuse polyplex-staining pattern was apparent. After 3 h, there was a clear increase in intracellular YOYO-1 iodide, as well as a loss of the punctate structures and a shift to a uniformly diffuse intracellular distribution (Figure 7 B) . Although the staining pattern alone cannot confi rm cytoplasmic localization of these polyplexes, the endosomal escape/cytoplasmic release of at least some of the polyplexes is a likely explanation; [ 31 ] however, further experiments would be needed to verify this phenomenon.
Flow cytometry was used to quantify the effi ciency of cellular uptake and the amount of intracellular YOYO-1 iodide-labeled siRNA polyplexes (Figure 7 C,D) . Following 1 h of polyplex exposure, the fraction of cells that had internalized siRNA/mPEGb -P(APNBMA) 23.6 polyplexes was comparable to the fraction that had internalized Lipofectamine preparations. Notably, the uptake effi ciency of siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes continued to increase more signifi cantly than that of siRNA/ Lipofectamine assemblies, whose uptake effi ciency remained constant after 2 h (Figure 7 C) at 36 ± 8% of cells with internalized siRNA/Lipofectamine. Previous studies have indicated comparable levels of cellular uptake under similar experimental conditions using siRNA/Lipofectamine assemblies in NIH/3T3 cells. For example, Kang et al. [ 32 ] reported ≈45% uptake following a 4 h transfection using a 9 n M siRNA/Lipofectamine solution. The average intracellular concentration of siRNA also increased up to 3 h post-transfection for the mPEGb -P(APNBMA) 23.6 polyplexes but remained constant for siRNA/ Lipofectamine assemblies (Figure 7 D) . PDMAEMA-containing block copolymers have similarly indicated near 100% cellular uptake in the preparation of siRNA delivery structures. [ 9a ] Several studies have indicated that enhanced cellular uptake of gene delivery polyplexes could be due to excess polycations that remain free in solution after polyplex formation. [ 33 ] 
NIH/3T3 Cell Viability
Numerous studies have indicated signifi cant cellular toxicity when using cationic polymers due to non-specifi c interactions with the cell surface and subsequent membrane disruption. [ 34 ] However, as previously demonstrated, mPEG-b -P(APNBMA) copolymers exhibited signifi cantly reduced cytotoxicity as compared to PEI, and pDNA/mPEG-b -P(APNBMA) 7.9 polyplexes exhibited minimal cytotoxicity both with and without UV irradiation. [ 19 ] Thus, we verifi ed the expected lack of cytotoxicity in cell populations transfected by siRNA polyplexes under similar conditions using the Alamar Blue (AB) cell survival assay. AB-based quantifi cation revealed 90% cell survival in all samples, and no additive/synergistic effects were found in cells that were treated with UV light in combination with siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes versus UV light alone ( Figure 8 ). As anticipated, these results indicated similar biocompatibility of the siRNA assemblies as noted in pDNA/mPEG-b -P(APNBMA) 7.9 polyplexes, suggesting their potential for further in vitro and in vivo delivery applications. Additionally, cells treated with siRNA/PEI ( N / P = 6) and siRNA/Lipofectamine indicated 81% and 82% viability, respectively, demonstrated improved biocompatibility of mPEG-b -P(APNBMA) n polymers.
Gene Silencing Capacity of Photocleavable Polyplexes
Based on the fi nding of triggered siRNA release in the characterization of polyplexes in cell-free studies, we also sought to test the on/off binding and silencing capacity of siRNA/mPEGb -P(APNBMA) 23.6 polyplexes in NIH/3T3 cells using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a target ( Figure 9 ). Cells were transfected for 3 h and then irradiated for 20 min, as the fl uorescence microscopy analyses had indicated the robust cytoplasmic distribution of the polyplexes within the 3 h time frame (Figure 7 B ). Cells transfected with anti-GAPDH siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes exhibited a signifi cantly higher level of GAPDH silencing following UV irradiation than cells treated with Lipofectamine assemblies, and moreover, these irradiated cells also exhibited enhanced silencing as compared to siRNA/mPEG-b -P(APNBMA) 23.6 treated cells in the absence of UV irradiation. Specifi cally, quantifi cation of the integrated optical density of GAPDH bands obtained through Western blot analysis indicated a 65 ± 4% ( n = 4) reduction in GAPDH levels for cells transfected with siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes and UV light, but no reduction in GAPDH levels in cells transfected with the siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes in the absence of UV light, and only a ≈30% reduction in GAPDH levels in cells transfected with Lipofectamine. The silencing behavior was specifi c to GAPDH, as delivery of nontargeting siRNA (ONTARGETplus nontargeting siRNA) only minimally affected GAPDH levels. These results highlight the unique capability of siRNA/ mPEG-b -P(APNBMA) 23.6 polyplexes to maintain stable association within cells in the absence of light. Additionally, ≈70% reduction in GAPDH levels indicated an enhanced genesilencing capacity compared to several other stimuli-responsive siRNA carriers, which report ≈50% protein silencing in response to changes in enzyme concentration and pH. [ 35 ] Based on the combined siRNA release and gene-silencing studies, it is 23.6 polyplexes ( N / P = 4) following a A) 1 h, and B) 3 h transfection. siRNA was labeled with YOYO-1 iodide (green); the nucleus was stained with Hoechst (blue). Arrows indicate punctate polyplex structures, and the scale bar represents 25 µm. Quantifi cation of YOYO-1-labeled siRNA/Lipofectamine RNAiMax (black) and siRNA/ mPEG-b -P(APNBMA) 23.6 (light gray) assemblies using fl ow cytometry: C) uptake as a percentage of cells that internalized lipoplexes or polyplexes, and D) the mean fl uorescence intensity (MFI, arbitrary units) of the cells that had internalized lipoplexes or polyplexes. Each data point represents the mean ± standard deviation for a total of three separately prepared samples. An asterisk (*) indicates a statistically signifi cant difference at a given time point between the mPEG-b -P(APNBMA) 23.6 polyplexes and the Lipofectamine lipoplexes ( p < 0.001).
worth noting that complete siRNA release from the irradiated polyplexes does not appear to be necessary for gene silencing, as only 15% free siRNA (based on siRNA release in gel electrophoresis following 20 min of UV irradiation) was required to obtain this silencing effect. The studies presented in this work highlight the potential of mPEG-b -P(APNBMA) n polymers to direct siRNA delivery and further reveal an enhanced silencing capacity of mPEG-b -P(APNBMA) 23 .6 compared to a number of light-responsive siRNA delivery carriers. [ 17b , 18 ] 
Conclusion
We demonstrated a novel photoresponsive system for localized cytoplasmic delivery and light-activated release of siRNA. mPEG-b -P(APNBMA) 23.6 provided enhanced siRNA binding to form salt-stable copolymer-based polyplexes that resisted aggregation following incubation in PBS, as compared to substantial growth for siRNA/PEI polyplexes (to >1 µm in diameter). [ 25 ] Serum exposure of siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes indicated tight association, in contrast to poly( L -lysine)-based polyplexes that showed >90% siRNA dissociation following 1 h of serum incubation.
[ 5b ] Delivery of mPEG-b -P(APNBMA) 23.6 polyplexes to NIH/3T3 cells facilitated >80% cellular uptake compared to 40% for Lipofectamine lipoplexes, and cytoplasmic release of siRNA-containing polyplexes within 3 h of polyplex exposure. UV irradiation of siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes cleaved the o -NB and facilitated charge reversal on the polymer backbone and siRNA release. Furthermore, genesilencing experiments revealed the exquisite specifi city and utility of this delivery approach. Specifi cally, by stimulating the photoresponsive polyplexes with UV light, we achieved ≈70% reduction in protein levels, as compared to no changes in protein levels for samples treated with siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes without irradiation, and only 30% reduction in Lipofectamine-treated cells. We anticipate that the capacity for effi cient cytoplasmic release and distribution, as well as the user-controlled release mechanism allowing for on/ off control of siRNA binding and activity, will introduce significant versatility into the delivery platform relevant to a range of biological applications in developmental biology, regenerative medicine, and drug screening.
Experimental Section
Materials : Photocleavable mPEG-b -P(APNBMA) n (M n = 7900 g mol
, n = 7.9; M n = 13 100 g mol
, n = 23.6) polymers were grown off of a 5 kDa mPEG-Br macroinitiator via atom-transfer radical polymerization as previously described. [ 19 ] ON-TARGETplus siRNA (anti-GAPDH) as well as a nontargeting siRNA sequence were purchased from ThermoFisher Scientifi c (Pittsburgh, PA). Lipofectamine RNAiMax, and the bisintercalating dye, YOYO-1 iodide were purchased from Life Technologies (Grand Island, NY). RNase A and 25 kDa branched PEI were obtained from Sigma-Aldrich (St. Louis, MO). A bicinchoninic acid (BCA) protein assay kit and bovine serum albumin (BSA) were obtained from Pierce (Rockford, IL). Dulbecco's modifi cation of Eagle's medium (DMEM) and PBS (150 m M NaCl) solutions were purchased from Corning Life Sciences -Mediatech Inc. (Manassas, VA). The ECL Plus Western Blotting Detection Kit was obtained from GE Healthcare Bioscience (Buckinghamshire, UK). Antibodies for Western blotting were purchased from AbCam (Cambridge, CA). Other Western blotting reagents were obtained from Pierce Biotechnology (Rockford, IL, USA). All other cell culture reagents were purchased from Fisher Scientifi c (Pittsburgh, PA).
siRNA Polyplex Formation and Characterization : Polyplexes were formed using mixtures of the ON-TARGETplus siRNA and mPEG-b -P(APNBMA) polymers. Prior to complexation, siRNA solutions were prepared at 40 µg mL −1 in 20 m M HEPES buffer, pH 6.0. Polyplexes were formed by the addition of polymer solution to an equal volume of siRNA solution followed by gentle vortexing. Polymer solutions contained polymer over the range of concentrations appropriate to form polyplexes at the desired N / P ratios. Polyplexes were incubated at room temperature for 10 min prior to further analyses. Polyplex formation was analyzed using agarose gel electrophoresis. For electrophoresis, 25 µL of polyplex solution was added to 5 µL of loading solution (3:7 (v/v) glycerol/water). Subsequently, the polyplex solution was added to the wells of a 4.0 wt% agarose gel containing 0.5 µg mL −1 of ethidium bromide. Gels were run at 100 V for 1 h and subsequently imaged using a Bio-Rad Gel Doc XR (Hercules, CA). Polyplexes (75 µL of solution) were mixed with 200 µL HEPES buffer, PBS, or Opti-MEM, and then incubated at 23 °C for either 1 or 3 h prior to particle size determination. A CNI Optoelectronics Co., Ltd. (Changchun, China) 532 nm, 427.6 mW laser, coupled with a Brookhaven Instruments Corporation (Holtsville, NY) BI-200SM goniometer equipped with an inline 532 nm fi lter from Intor, Inc. (Socorro, NM), was used for DLS analyses. The intensity autocorrelation function was recorded at an angle of 90° and analyzed using a quadratic cumulant fi t. All light scattering experiments were performed at 25 °C.
Stability of mPEG-b-P(APNBMA) 23.6 Polyplexes Against Heparin : Polyplexes containing 1 µg of siRNA were formed as described using either mPEG-b -P(APNBMA) 23.6 or PEI and the polyplexes subsequently wileyonlinelibrary.comwere incubated with heparin solutions for 30 min at 37 °C; the heparin solutions were used over the reported range of heparin/siRNA (w/w) ratios. Then, samples were analyzed by electrophoresis as described herein. Serum Stability of siRNA/mPEG-b-P(APNBMA) 23.6 Polyplexes : The serum stability of siRNA/mPEG-b -P(APNBMA) 23.6 polyplexes was monitored by two complementary approaches. Whole mouse serum was used to investigate the stability against serum-mediated disassembly, and RNase A treatment was used to monitor siRNA degradation following nuclease exposure. For serum stability analysis, free siRNA (1 µg) or mPEG-b -P(APNBMA) 23.6 polyplexes containing 1 µg of siRNA were incubated in 25 µL of whole mouse serum for 2 h. The serum nuclease activity was terminated by adding 20 µL of a buffer composed of 0.16 M ethylene diamine tetraacetic acid (EDTA), 0.67 M NaOH, and 0.16 M NaCl, and the solutions were placed on ice for 10 min prior to analysis by agarose gel electrophoresis.
RNase Stability of siRNA/mPEG-b-P(APNBMA) 23.6 Polyplexes : To monitor polyplex resistance to enzymatic degradation, RNase A was added to prepared polyplex samples containing 1 µg of siRNA, resulting in solution concentrations of 5 µg mL −1 siRNA and 0.5 µg mL −1 RNase A. These solutions were incubated for 5 min at 37 °C, and then the RNase activity was terminated by adding 8 µL termination buffer. siRNA release was initiated by adding 2 µL of 10 mg mL −1 sodium dodecyl sulfate (SDS) solution and incubating the resulting polyplex-SDS mixture for 5 min. The extent of siRNA degradation was subsequently analyzed by agarose gel electrophoresis.
Photocleavage and siRNA Release : Photocleavage studies were performed using 300 µL of either the siRNA polyplex solution or free mPEG-b -P(APNBMA) n solution. These samples were loaded into a chamber that was prepared by sealing two glass slides with a rubber gasket. The chamber was irradiated with 365 nm light at 200 W m −2 (Omnicure S2000, Lumen Dynamics, Mississauga, Ontario, Canada) for 0, 5, 10, 20, 40, or 60 min. After irradiation, samples were removed from the chamber and collected for UV-visible (UV-vis) absorbance measurements and agarose gel electrophoresis analyses. Absorbance measurements were performed using a Thermo Scientifi c NanoDrop 1000 Spectrophotometer (Waltham, MA).
Cell Culture : Mouse embryonic fi broblast (NIH/3T3) cells were obtained from the American-Type Culture Collection (ATCC, Manassas, VA). The cells were cultured according to ATCC protocols at 37 °C and 5 vol% CO 2 in DMEM supplemented with 10 vol% fetal bovine serum (FBS) and 1 vol% penicillin-streptomycin.
Cell Transfection : For transfections with mPEG-b -P(APNBMA) polymers, polyplexes were formed as described. Lipofectamine RNAiMax assemblies were formed according to the manufacturer's protocols. Cells were seeded into six-well plates at a density of 15 000 cells cm −2 and allowed to adhere for 24 h. Growth medium was subsequently replaced with Opti-MEM and polyplex solutions or Lipofectamine RNAiMax solutions containing 3.0 pmol siRNA cm −2 were added dropwise to the cells at 24 h post-seeding. After a 3-h incubation with the transfection reagents, the cells were washed with PBS and complete growth medium was added to each well. For transfections with UV treatment, cells were allowed to recover for 30 min in complete growth medium following the 3 h transfection. Subsequently, the medium was replaced with Opti-MEM and the samples were placed on a hot plate set to 37 °C and irradiated for 20 min at 365 nm ( I 0 = 200 W m −2 ). Cells then were washed with PBS and supplemented with complete growth medium for the remainder of the culture period.
Cellular Uptake Analyses : Polyplex internalization was monitored by two complementary approaches. Polyplex distributions were visualized using cell-staining analyses, and fl ow cytometry was used as a quantitative measure of uptake. For both approaches, siRNA was labeled for detection by adding 1.5 eq. of YOYO-1 iodide and incubating the labeling mixture at 37 °C for 1 h prior to polyplex formation. To prepare cells for uptake analyses, cells were synchronized by serum starvation. Cells were plated at a density of 2000 cells cm −2 and incubated overnight. For synchronization, the medium was removed and replaced with fresh DMEM containing 0.75 vol% FBS and 1 vol% antibiotics, according to standard procedures. [ 36 ] The cells were grown for an additional 48 h, and then the cells were released from starvation by replacing the low-serum medium with fully supplemented growth medium containing 10 vol% serum and 1 vol% antibiotics. Transfections were performed 12 h after synchronization, using polyplex suspensions containing 3.0 pmol siRNA cm −2 . Transfections were halted after 1, 2, or 3 h of polyplex exposure by removing the transfection media, rinsing the cells with PBS, washing with 10 µg mL −1 heparin solutions to remove extracellular polyplexes, [ 37 ] and washing again with PBS. For cell staining, cells were fi xed with 4% paraformaldehyde in PBS for 15 min, permeabilized with 0.2 vol% Tween-20 in PBS (0.2% PBSt), and blocked with 3% BSA in 0.2% PBSt. Cells were stained with 4 µg mL −1 Hoechst dye solution and stored at 4 °C prior to imaging. For fl ow cytometry analyses, cells were collected for analysis by standard trypsinmediated collection protocols. Subsequently, cells were resuspended in PBS, fi ltered through a 35-µm nylon mesh to remove aggregates, and stored at 4 °C until analysis. Polyplex uptake effi ciency was calculated as the percentage of cells containing polyplexes. Specifi cally, scatter plots from untransfected cells were gated for autofl uorescence and the percentage of cells with fl uorescence levels above the autofl uorescence threshold was determined by comparison with the gate position. A total of 10 000 cells were analyzed for each sample.
Cell Toxicity : Polyplex and UV toxicity were evaluated in NIH/3T3 cells using the AB assay according to the manufacturer's protocols. Cells were seeded into six-well plates at a density of 15 000 cells cm −2 and allowed to adhere for 24 h prior to toxicity analyses. The cells were rinsed with PBS, transfected with polyplex solutions, and UV treated as described above. Subsequently, the cells were rinsed with PBS and the medium was replaced with complete growth medium. After 48 h, AB was added directly into the culture medium to a fi nal concentration of 10 vol%, and the AB-containing solutions were incubated with the cells for an additional 6 h at 37 °C, 5 vol% CO 2 . AB fl uorescence was measured using a GloMax-multi detection system plate reader (Promega, Madison, WI). To determine the baseline fl uorescence, AB was added to media without cells.
Western Blot Analysis : siRNA-mediated gene silencing was analyzed by standard Western blotting analyses. After a 48-h transfection, protein was extracted from NIH/3T3 cells by incubating the cells with a lysis solution composed of 0.5 vol% Triton X-100, 0.5% sodium deoxycholate, 150 m M NaCl, 5 m M Tris-HCl (pH 7.4), 5 m M EDTA, and 1× Halt Protease and Phosphatase Inhibitor cocktail. For each sample, total protein content was measured using a BCA Protein Assay Reagent Kit. Equal amounts of cellular protein from each cell extract were subjected to 4%-20% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and the separated proteins were subsequently transferred onto a poly(vinylidene fl uoride) membrane. The membrane was blocked in 5 vol% BSA in TrisHCl-buffered saline (50 m M Tris-HCl, pH 7.4, 150 m M NaCl) containing 0.1 vol% Tween 20 (TBSt) for 1 h at room temperature, and then the membrane was incubated with an anti-GAPDH rabbit monoclonal IgG primary antibody (0.4 µg mL −1 in TBSt) overnight at 4 °C. Subsequently, the membrane was incubated with a solution of goat anti-rabbit polyclonal IgG antibody conjugated to horseradish peroxidase (HRP) (0.04 µg mL −1 in TBSt) for 1 h at room temperature. Target proteins were visualized with the ECL Plus chemiluminescent substrate. Subsequently, the membrane was stripped for 15 min using Restore Western Blot stripping buffer and probed for actin using anti-actin rabbit polyclonal IgG (1 µg mL −1 in TBSt) and a goat anti-rabbit polyclonal IgG HRPconjugated secondary antibody. The chemiluminescence signal was quantifi ed with the aid of ImageJ software.
